Colossal Biosciences

Colossal Biosciences is one of the...

• Unicorn.

Acquisition, funding and merger involving Colossal Biosciences.

• Colossal Biosciences has just announced a $150 Million fundraising (posted on February 3 2023).

View the org chart displaying its 17 main executives

Most searched biographies at Colossal Biosciences

• Sarah Grant, Chief of Staff
• Matt James, Chief Animal Officer
• Samuel Singer, Chief Financial Officer

Popular executive movements at Colossal Biosciences

• Beth Shapiro has joined the company as Chief Scientific Officer  (posted on March 20 2024).
• Emily Castel has joined the company as Chief Marketing Officer  (posted on February 2 2024).

Create your alert
to follow the executive moves at Colossal Biosciences.

Colossal Biosciences has 2,285 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Colossal Biosciences

• Learn how we are getting to a better world.
• Learn how we are getting to a better world.

Social media about Colossal Biosciences

• Colossal Biosciences on Wikipedia, Google News & Yahoo Finance
• Colossal Biosciences on LinkedIn, Twitter & YouTube

Contact by email its executives including Samuel Singer

Call Colossal Biosciences at +1 512...

View the org chart

Register to receive your alert

Report an error